(UroToday.com) In a point and counterpoint format at the 2020 Society of Urologic Oncology (SUO) Annual Virtual Meeting discussing whether prostate-specific membrane antigen (PSMA) PET-CT is ready for prime-time use, Dr. Matthew Cooperberg took the counterpoint approach that PSMA PET-CT is not yet ready for prime-time use.